Digestive Health

Pharmacists can counsel patients on how to best manage heartburn and GERD symptoms.

Recent research offers insight into the global prevalence of gastrointestinal disorders.

Regular use of proton pump inhibitors could increase the risk of developing diabetes, but the findings are based off an observational study.

Results of 2 recent studies suggested a higher risk of developing osteoporosis in patients with inflammatory bowel disease.

The sodium sulfate, magnesium sulfate, and potassium chloride tablet gives patients an alternative to liquid-based colonoscopy preparations.

Eli Lilly reported new efficacy and safety data for mirikizumab in moderate-to-severe Crohn disease.

An altered composition of the gut microbiota might play a role in major depressive disorder and affect treatment response.

Results of the phase 2b study showed that, in its highest-dosing arm, 21% of patients with left-sided ulcerative colitis were in clinical remission.

Higher cumulative exposure to systemic antibiotic therapy may be associated with a greater risk of new-onset inflammatory bowel disease.

The study investigators used artificial intelligence to analyze gut microbiome data in individuals with and without cardiovascular disease.

What supplements are patients looking for the most, and how can pharmacists help?

The Chinese Gastroenterology Expert Group and the Chinese Society of Gastroenterology published new management consensus for digestive disorders in patients with the coronavirus disease 2019.

With their knowledge and experience, pharmacists can be quite helpful to patients with GERD.

The launch marks Ferring’s second treatment this month specified for Crohn disease.

Prepare to counsel patients on microbiome-related products.

Pharmacists continue to report famotidine shortages following ranitidine recalls and a recent report suggesting use in COVID-19.

Pharmacists can counsel patients with GERD on strategies to address their symptoms.

Type 2 diabetes risk prediction is improved by observing changes in gut bacteria, a study finds.

Pharmacists can and must play an active role in guiding patients on the selection of laxatives which are supported by sound evidence.

Though the relationship between genetics and gut-dwelling bacteria is still a realm of mystery, new research has begun a new step towards better understanding how one affects the other.

The first and only one of its kind, metoclopramide nasal spray offers relief to often debilitating symptoms of the gastrointestinal disease.

IW-3718, an investigational adjunct therapy to proton pump inhibitors for refractory GERD, showed favorable results in reducing heartburn severity and other symptoms.